Financial Statements · Financial Reporting
AS Bravo Pharmaceuticals
Official identifier 14159974Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 28 Jul 2025
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 284,559 |
| Balance sheet | Cash and cash equivalents | 75 |
| Balance sheet | Current assets | 46,661 |
| Balance sheet | Current liabilities | 242,772 |
| Balance sheet | Equity | 41,787 |
| Balance sheet | Share capital at nominal value | 335,337 |
| Balance sheet | Non-current assets | 237,898 |
| Balance sheet | Retained earnings (loss) from previous periods | -225,983 |
| Kahjumi katmise ettepanek | Retained earnings (loss) from previous periods | -225,983 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -3,614 |
| Income statement scheme 1 | Labour costs | -33,308 |
| Income statement scheme 1 | Revenue | 28,873 |
| Income statement scheme 1 | Annual period profit / loss | -71,167 |
| Income statement scheme 1 | Operating profit (loss) | -71,298 |
| Income statement scheme 1 | Profit (loss) before income tax | -71,167 |
| Note: Labour costs | Employees | 2 |
| Note: Labour costs | Labour costs | 33,308 |
Linked company
Company: AS Bravo Pharmaceuticals